Skip to content
info@adcendo.dk
Search for:
Home
About
Our Technology And Target
Pipeline
Partnering and Investors
Team & Advisory Board
News
Contact
Pipeline
Christoffer Nielsen
2020-06-30T09:04:53+02:00
The observed expression profile of our novel target enables potential treatment of a range of rare as well as more common cancer indications.
Go to Top